Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus

NCT00798915 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Diabetes

Interventions

DRUG: Placebo
DRUG: Glucose-dependent Insulinotropic Polypeptide (GIP)
DRUG: Xenin-25
DRUG: Glucose-dependent Insulinotropic Polypeptide plus Xenin-25

Sponsor

Washington University School of Medicine

Collaborators

[object Object]